185 related articles for article (PubMed ID: 31876927)
1. Coronary Sinus Neuropeptide Y Levels and Adverse Outcomes in Patients With Stable Chronic Heart Failure.
Ajijola OA; Chatterjee NA; Gonzales MJ; Gornbein J; Liu K; Li D; Paterson DJ; Shivkumar K; Singh JP; Herring N
JAMA Cardiol; 2020 Mar; 5(3):318-325. PubMed ID: 31876927
[TBL] [Abstract][Full Text] [Related]
2. Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: the BIOCRT study.
Truong QA; Januzzi JL; Szymonifka J; Thai WE; Wai B; Lavender Z; Sharma U; Sandoval RM; Grunau ZS; Basnet S; Babatunde A; Ajijola OA; Min JK; Singh JP
Heart Rhythm; 2014 Dec; 11(12):2167-75. PubMed ID: 25014756
[TBL] [Abstract][Full Text] [Related]
3. NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure.
Stanciu AE; Stanciu MM; Vatasescu RG
Cytokine; 2018 Nov; 111():13-19. PubMed ID: 30098475
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes.
McDowell K; Adamson C; Jackson C; Campbell R; Welsh P; Petrie MC; McMurray JJV; Jhund PS; Herring N
Eur J Heart Fail; 2024 Jan; 26(1):107-116. PubMed ID: 37937329
[TBL] [Abstract][Full Text] [Related]
5. Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy.
Singh JP; Solomon SD; Fradley MG; Barac A; Kremer KA; Beck CA; Brown MW; McNitt S; Schleede S; Zareba W; Goldenberg I; Kutyifa V;
JAMA; 2019 Nov; 322(18):1799-1805. PubMed ID: 31714987
[TBL] [Abstract][Full Text] [Related]
6. Intrathoracic impedance changes reflect reverse left ventricular remodeling in response to cardiac resynchronization therapy in chronic heart failure patients.
Kaneshiro T; Suzuki H; Yamada S; Kamiyama Y; Saitoh S; Takeishi Y
Int Heart J; 2012; 53(4):249-52. PubMed ID: 22878804
[TBL] [Abstract][Full Text] [Related]
7. Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
Sommer A; Kronborg MB; Nørgaard BL; Poulsen SH; Bouchelouche K; Böttcher M; Jensen HK; Jensen JM; Kristensen J; Gerdes C; Mortensen PT; Nielsen JC
Eur J Heart Fail; 2016 Nov; 18(11):1365-1374. PubMed ID: 27087019
[TBL] [Abstract][Full Text] [Related]
8. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN
JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796
[TBL] [Abstract][Full Text] [Related]
9. Electrically vs. imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
Stephansen C; Sommer A; Kronborg MB; Jensen JM; Nørgaard BL; Gerdes C; Kristensen J; Jensen HK; Fyenbo DB; Bouchelouche K; Nielsen JC
Europace; 2019 Sep; 21(9):1369-1377. PubMed ID: 31274152
[TBL] [Abstract][Full Text] [Related]
10. Continued versus Suspended Cardiac Resynchronization Therapy after Left Ventricular Assist Device Implantation.
Roukoz H; Bhan A; Ravichandran A; Ahmed MM; Bhat G; Cowger J; Abdullah M; Dhawan R; Trivedi JR; Slaughter MS; Gopinathannair R
Sci Rep; 2020 Feb; 10(1):2573. PubMed ID: 32054868
[TBL] [Abstract][Full Text] [Related]
11. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
[TBL] [Abstract][Full Text] [Related]
12. Cardiometabolic Biomarkers and Their Temporal Patterns Predict Poor Outcome in Chronic Heart Failure (Bio-SHiFT Study).
Brankovic M; Akkerhuis KM; Mouthaan H; Brugts JJ; Manintveld OC; van Ramshorst J; Germans T; Umans V; Boersma E; Kardys I
J Clin Endocrinol Metab; 2018 Nov; 103(11):3954-3964. PubMed ID: 30113647
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction.
Herring N; Tapoulal N; Kalla M; Ye X; Borysova L; Lee R; Dall'Armellina E; Stanley C; Ascione R; Lu CJ; Banning AP; Choudhury RP; Neubauer S; Dora K; Kharbanda RK; Channon KM;
Eur Heart J; 2019 Jun; 40(24):1920-1929. PubMed ID: 30859228
[TBL] [Abstract][Full Text] [Related]
14. Prognosis associated with redo cardiac resynchronization therapy following complete device and lead extraction due to device-related infection.
Seifert M; Moeller V; Arya A; Schau T; Hoelschermann F; Butter C
Europace; 2018 May; 20(5):808-815. PubMed ID: 28398556
[TBL] [Abstract][Full Text] [Related]
15. Optimization of coronary sinus lead placement targeted to right-to-left delay in patients undergoing cardiac resynchronization therapy.
Oddone D; Solari D; Arena G; Mureddu R; Nangah R; Giorgi D; Senatore G; Bottoni N; Giaccardi M; Laffi M; Giammaria M; Sitta N; Marras E; Cipolla E; Di Lorenzo F; Carpi R; Brignole M
Europace; 2019 Mar; 21(3):502-510. PubMed ID: 30508076
[TBL] [Abstract][Full Text] [Related]
16. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiology Catheter-Facilitated coronary sinus cannulation and implantation of cardiac resynchronization therapy systems.
Manolis AS; Koulouris S; Tsiachris D
Hellenic J Cardiol; 2018; 59(1):26-33. PubMed ID: 28778735
[TBL] [Abstract][Full Text] [Related]
18. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.
Varma N; Sogaard P; Bax JJ; Abraham WT; Borer JS; Dickstein K; Singh JP; Gras D; Holzmeister J; Brugada J; Ruschitzka F
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29807890
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
[TBL] [Abstract][Full Text] [Related]
20. Coronary sinus lead delay index for optimization of coronary sinus lead placement.
Koç M; Kaypakli O; Gözübüyük G; Yıldıray Şahin D
Ann Noninvasive Electrocardiol; 2018 Jan; 23(1):. PubMed ID: 28557338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
